• Search
  • Advanced Search

Ahead-of-print

  • HOME
  • BROWSE ARTICLES
  • Ahead-of-print

Articles in E-pub version are posted online ahead of regular printed publication.

Review
Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
Received April 10, 2024  Accepted June 26, 2024  
View: 131   Download: 22
Editorial
Engineering HBV-specific T cells for treatment of HBV-related HCC and HBV infection: past, present and future
Antonio Bertoletti, Anthony T Tan
Received June 23, 2024  Accepted June 26, 2024  
View: 56   Download: 4
Original Article
UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL
Renyu Zhang, Can Li, Shuai Zhang, Lingmin Kong, Zekun Liu, Yixiao Guo, Ying Sun, Cong Zhang, Yule Yong, Jianjun Lv, Meng Lu, Man Liu, Dong Wu, Tianjiao Zhang, Haijiao Yang, Ding Wei, Zhinan Chen, Huijie Bian
Received April 7, 2024  Accepted June 24, 2024  
View: 142   Download: 26
Burden of Mortality from Hepatocellular Carcinoma and Biliary Tract Cancers by Race and Ethnicity and Sex in US, 2018-2023
Donghee Kim, Richie Manikat, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
Received April 29, 2024  Accepted June 20, 2024  
View: 166   Download: 6
Letter to the Editor
MAFLD-related hepatocellular carcinoma in China: An increasing problem
Xiangyu Wu, Wenjing Ni, Qianqian Chen, Junping Shi, Jie Li
Received May 22, 2024  Accepted June 17, 2024  
View: 146   Download: 13
Correspondence
Correspondence on Editorial regarding “Dynamic Assessment of Modified Quick Sequential Organ Failure Assessment in Acutely Deteriorated Patients with Chronic Liver Disease”
Do Seon Song, Dong Joon Kim
Received June 12, 2024  Accepted June 14, 2024  
View: 111   Download: 4
Editorial
Macrophage ATG16L1: potential candidate for MASH treatment
Junjie Yu
Received June 11, 2024  Accepted June 14, 2024  
View: 139   Download: 13
The impact of ischemia-free liver transplantation to improve the prognosis of recipients using functionally marginal liver grafts
Ho Joong Choi
Received June 4, 2024  Accepted June 6, 2024  
View: 162   Download: 8
Metformin and Statins and their role in reducing Hepatocellular Carcinoma Risk: Randomized trials are needed
Paul Y. Kwo
Received June 4, 2024  Accepted June 6, 2024  
View: 215   Download: 19
Meeting the challenges of HCC post SVR in the Post-DAA Era: A Path Forward
Seren M. Gedallovich, Paul Y. Kwo
Received June 3, 2024  Accepted June 6, 2024  
View: 152   Download: 7
Ursolic acid: A promising therapeutic agent for MASLD via inhibition of SPP1-induced Th17 cell differentiation
So Jung Kim, Jeongeun Hyun
Received May 31, 2024  Accepted June 6, 2024  
View: 247   Download: 23
Modified quick-SOFA score: can it enhance prognostic assessment for hospitalized patients with chronic liver diseases?
Simone Incicco, Salvatore Piano
Received May 30, 2024  Accepted May 31, 2024  
View: 164   Download: 5
Original Article
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis
Juchul Hwang, Hyeyoung Hwang, Hyunjae Shin, Bo Hyun Kim, Seong Hee Kang, Jeong-Ju Yoo, Mi Young Choi, Dong eun Lee, Dae Won Jun, Yuri Cho
Received September 27, 2023  Accepted June 1, 2024  
View: 459   Download: 33
Correspondence
Correspondence on editorial regarding “Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?”
Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
Received May 24, 2024  Accepted May 29, 2024  
View: 310   Download: 14
Original Article
Genetically redirected HBV-specific T cells target HBsAg-positive hepatocytes and primary lesions in HBV-associated HCC
Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du
Received January 20, 2024  Accepted May 28, 2024  
View: 414   Download: 52
Editorial
MAFLD Is A Ubiquitous Latent Cofactor in Viral- and Alcoholic-related Hepatocellular Carcinoma
Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, Keisuke Amano, Takumi Kawaguchi
Received May 18, 2024  Accepted May 20, 2024  
View: 393   Download: 25
Correspondence
Correspondence on Editorial regarding “Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: a gateway to personalized medicine”
Su Bin Lim, Hyo Jung Cho
Received May 16, 2024  Accepted May 19, 2024  
View: 322   Download: 14
Reply to Unlocking the future: machine learning sheds light on prognostication for early-stage hepatocellular carcinoma
Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
Received May 16, 2024  Accepted May 19, 2024  
View: 303   Download: 7
Reply to Correspondence
Reply to correspondence: “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
Eileen Laurel Yoon, Dae Won Jun
Received May 15, 2024  Accepted May 19, 2024  
View: 317   Download: 8
Letter to the Editor
Equivalent Prevalence and Progression of Chronic Kidney Disease in NAFLD and MASLD
Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
Received April 15, 2024  Accepted May 20, 2024  
View: 385   Download: 39
Correspondence
Correspondence on Letter regarding “Liver Sinusoidal Endothelial Cell: An Important Yet Often Overlooked Player in the Liver Fibrosis”
Jiaorong Qu, Le Wang, Xiaojiaoyang Li
Received May 14, 2024  Accepted May 15, 2024  
View: 299   Download: 22
Editorial
Unveiling Etiology-Specific Blood Biomarkers in Hepatocellular Carcinoma: A Gateway to Personalized Medicine
Joseph C. Ahn, Ju Dong Yang
Received May 10, 2024  Accepted May 13, 2024  
View: 345   Download: 6
Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure
Hae Lim Lee, Jeong Won Jang
Received May 9, 2024  Accepted May 13, 2024  
View: 225   Download: 18
Original Article
Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction
Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim
Received January 22, 2024  Accepted May 13, 2024  
View: 832   Download: 111
Editorial
Unlocking the Role of Liver Sinusoidal Endothelial Cells: Key Players in Liver Fibrosis
Yasuko Iwakiri
Received May 8, 2024  Accepted May 9, 2024  
View: 322   Download: 39
Letter to the Editor
Changing from NAFLD to MASLD: Cumulative incidence of gallstones between patients with NAFLD and those with MASLD in Asia
Shuhei Fukunaga, Tomoyuki Nakane, Michita Mukasa, Hidetoshi Takedatsu, Takumi Kawaguchi
Received April 7, 2024  Accepted May 10, 2024  
View: 342   Download: 27  Crossref: 1
Original Article
Macrophage ATG16L1 expression suppresses MASH progression by promoting lipophagy
Qi Wang, Qingfa Bu, Zibo Xu, Yuan Liang, Jinren Zhou, Yufeng Pan, Haoming Zhou, Ling Lu
Received February 13, 2024  Accepted May 10, 2024  
View: 727   Download: 113
Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study
Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
Received January 20, 2024  Accepted May 9, 2024  
View: 416   Download: 59
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and the risk of hepatocellular carcinoma: a nationwide cohort study
Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, Seulggie Choi, Sun Jae Park, Hye Jun Kim, Gyeongsil Lee, Joung Sik Son, Heejoon Jang, Dong Hyeon Lee, Meng Sha, Lei Chen, Won Kim, Sang Min Park
Received February 4, 2024  Accepted May 7, 2024  
View: 552   Download: 66
Editorial
Unlocking the future: machine learning sheds light on prognostication for early-stage hepatocellular carcinoma
Junlong Dai, Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
Received May 3, 2024  Accepted May 4, 2024  
View: 305   Download: 16
Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?
Naoshi Nishida
Received May 2, 2024  Accepted May 3, 2024  
View: 302   Download: 41
Reply to Correspondence
Complement Proteins and Liver Diseases: A Response to the Correspondence
Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
Received April 30, 2024  Accepted April 30, 2024  
View: 434   Download: 31
Letter to the Editor
Functional cure of CHB encounters resmetirom
Nai-Bin Yang, Wai-Kay Seto, Ming-Hua Zheng
Received April 25, 2024  Accepted April 29, 2024  
View: 564   Download: 53
Review
Unmet needs in the post-DAA era: the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
Received March 1, 2024  Accepted April 26, 2024  
View: 524   Download: 57
Correspondence
Reply to: “Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization”
Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu
Received April 16, 2024  Accepted April 19, 2024  
View: 391   Download: 15
Original Article
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi‐Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chi-Yi Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Wan-Long, Ming-Jong Bair, Ming-Lung Yu
Received January 16, 2024  Accepted April 18, 2025  
View: 1015   Download: 93
Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis
Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone Strasser, Jacob George
Received February 15, 2024  Accepted April 15, 2024  
View: 1065   Download: 130  Crossref: 1
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against non-alcoholic fatty liver disease
Yiyuan Zheng, Lina Zhao, Zhekun Xiong, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Yugang Fu, Simin Gu, Chong Chen, Jiacheng Li, Yingying Zhu, Jing Liu, Fengbin Liu, Yong Li
Received January 18, 2024  Accepted April 15, 2024  
View: 1065   Download: 175
Reply to correspondence
Reply to correspondence regarding “Evaluation of the histological scoring systems for autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis”
Atsumasa Komori
Received April 9, 2024  Accepted April 10, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0242    [Epub ahead of print]
View: 549   Download: 15
Reply to Correspondence
Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B”
Pin-Nan Cheng, Ming-Lung Yu
Received April 5, 2024  Accepted April 9, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0228    [Epub ahead of print]
View: 496   Download: 21
Original Article
Ischemia-free liver transplantation improves the prognosis of recipients using Functioned Marginal Liver grafts
Shuai Wang, Xiaohong Lin, Yunhua Tang, Yichen Liang, Min Zhang, Zhonghao Xie, Yiwen Guo, Yuqi Dong, Qiang Zhao, Zhiyong Guo, Dongping Wang, Xiaoshun He, Weiqiang Ju, Maogen Chen
Received February 22, 2024  Accepted April 11, 2024  
View: 683   Download: 72
Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma
Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
Received February 9, 2024  Accepted April 10, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0103    [Epub ahead of print]
View: 874   Download: 78
Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment
Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Jin Mo Yang, Dong Joon Kim, Ashok Kumar Choudhury, Vinod Arora, Shiv Kumar Sarin
Received December 27, 2023  Accepted April 9, 2024  
DOI: https://doi.org/10.3350/cmh.2023.0563    [Epub ahead of print]
View: 719   Download: 38
Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients
Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery
Received December 16, 2023  Accepted March 25, 2024  
DOI: https://doi.org/10.3350/cmh.2023.0535    [Epub ahead of print]
View: 759   Download: 61
Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
Received January 17, 2024  Accepted March 14, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0042    [Epub ahead of print]
View: 1190   Download: 154
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
Young Eun Chon, Dong Yun Kim, Mina Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Yeonjung Ha, Joo Ho Lee, Kwan Sik Lee, Beodeul Kang, Jung Sun Kim, Hong Jae Chon, Do Young Kim
Received December 21, 2023  Accepted March 8, 2024  
DOI: https://doi.org/10.3350/cmh.2023.0553    [Epub ahead of print]
View: 1112   Download: 192
Letter to the Editor
Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
Received March 1, 2024  Accepted March 5, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0157    [Epub ahead of print]
View: 860   Download: 95  Crossref: 2
Snapshot
Examining the therapeutic landscape of beta-blockers in portal hypertension
Anna Brujats, Càndid Villanueva
Received February 24, 2024  Accepted March 4, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0144    [Epub ahead of print]
View: 599   Download: 30
Review
Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis
Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li
Received January 11, 2024  Accepted February 26, 2024  
DOI: https://doi.org/10.3350/cmh.2024.0022    [Epub ahead of print]
View: 1154   Download: 147
Snapshot
Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen
Received December 21, 2023  Accepted December 28, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0555    [Epub ahead of print]
View: 5087   Download: 56

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1166
TOTAL : 1903108
Close layer